Positioned as one of the leading law firms for pharmaceuticals IPR in India, S&S serves a broad range of solutions to its domestic as well as global clients
Bitika Sharma, Senior Partner
Home to the largest number of US-FDA compliant pharmaceuticals plants outside of the US, India has a thriving pharmaceuticals industry that is undergoing immense growth and transformation, leading to a demand for quality IPR solutions. Governmental support through PLI schemes, Make in India initiative, development of bulk drug plants in several states, has enabled development of low cost generic patented drugs. IPR consultants are in high demand to meet the increasing needs for patent application filings, and expedited grants. Creation of IPDs, increased public awareness about IPRs, and regulatory advancements have significantly increased the demand for IPR experts.
Assisting clients expertly to navigate the complexities of the ever-evolving regulatory framework is Singh & Singh Law Firm LLP (S&S), a Delhi-based legal firm specializing in IPR. Leveraging decades of experience in the domain, the firm effectively supports clients through a labyrinth of legal challenges for the protection of IPR, encompassing regulatory and compliance complications and delays in gaining approvals, which is worsened by quick counterfeiting practices in the market, and judicial delays.
Diversified Expertise
Representing clients in both prosecution and litigation capacities, the firm stands out for the diversified team of professionals that bring unmatched expertise in IPR across categories including patents, design, copyrights, and trademarks. The firm offers a complete range of IPR services for the pharmaceuticals sector encompassing search and clearance, FTO opinions and risk assessment, filing and prosecution, litigation and dispute resolution, drafting of agreements as license agreements, negotiation agreements, technology transfer, and sub-licensing, petitions for pharmaceutical pricing, and anti-counterfeiting actions.
The company has also established strong global connections and tie-ups that enable it to offer international IPR strategy and cross border protection. The company’s patent agents and lawyers also bring sector niche expertise across industries including pharmaceuticals, biosimilars, and life sciences.
“We are one of the oldest specialized IPR firms in India with a special focus on the pharmaceuticals sector, and have seen first-hand the evolution of IPR jurisprudence in India.
We offer immense experience in IPR and a diverse team of individuals well equipped to understand the nuances of the industry and tackle the various challenges flawlessly. We also act in an advisory role from innovation inception till the product launch and the post-sales challenges. Further, our specialized patent agents bring domain knowledge to assist the lawyers with their technical expertise, and thereby provide the client comprehensive consultancy”, shares Bitika Sharma, Senior Partner, S&S.
S&S has been a part of India’s prominent pharma IPR cases including Roche v. Cipla, Novartis vs. UOI, as well as the first biosimilar case of abbreviated clinical trials of Trastuzumab. These experiences demonstrate the company’s expansive experience. Offering holistic services for IPR in pharma, the firm simplifies the process for clients who no longer need to struggle for correctly segregating their innovation under one of the many categories as S&S assists them in doing everything from start to finish.
Positioned as one of the leading law firms for pharmaceuticals IPR in India, S&S serves a broad range of solutions to its domestic as well as global clientsBitika Sharma, Senior Partner
Growth Trajectory
Positioned as one of the leading law firms for pharmaceuticals IPR in India, S&S serves a broad range of solutions to its domestic as well as global clients, utilizing the expertise of its dynamic and highly qualified team of professionals, 50 per cent of whom are females. The expertise that each professional brings enables the firm to identify the unique requirements of each client, dig down to the core issue, and offer tailored advisory and other solutions accordingly.
This not only makes the firm stand out, but has also enabled it to grow immensely over the years, expanding its geographical presence beyond India’s border, to penetrate multiple countries including the USA, UK, Canada, and Australia, to name a few, catering to a host of prestigious clients including the FMC Corporation, Monsanto, Illumina, Philips, Ericsson, Dolby, and more.
Despite engaging with a global client base, the firm also excels in maintaining an amenable work environment, facilitating smooth workflow. The firm also focuses on encouraging junior associates to partake in strategy meetings to learn strategy creation for handling the unique needs of every case.
“We pay special attention to junior associates to ensure that they explore every nuance of prosecution and litigation and do not restrict themselves to only one or two practices. We also release a regular newsletter featuring the latest case updates and developments in the legal field which is produced with the effort of junior advocates. Our lawyers are encouraged to write articles and opinion pieces on topical judgments and issues, which are published on the firm’s website and various other academic journals and blogs. These practices ensure our workforce is always current with the latest advancements”, adds Bitika.
Such proactive measures are an essential part of life at S&S, and have extensively boosted the firm’s growth. Keeping on this growth trajectory, the firm has charted out strategies for the coming years. S&S aspires to improve its sector-specific expertise, for which it plans to hire more lawyers, and patent agents. Another goal that the firm has planned is expanding its geographical reach by attending several international conferences. To equip its team with the right tools, the firm also plans to integrate new technologies into its legal services that aim to optimize solutions seamlessly.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")